Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction.
about
Regulation of inflammation in cancer by eicosanoidsScience review: searching for gene candidates in acute lung injury.Pattern Recognition Receptors in Cancer Progression and MetastasisObesity and cancer: at the crossroads of cellular metabolism and proliferationIn silico experimentation of glioma microenvironment development and anti-tumor therapyMyeloid cells in the tumor microenvironment: Role of adenosineReducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acidsIL-1 does not reverse the anti-proliferative effect of aspirin in breast cancer cellsSystematic review and meta-analysis on the association between IL-1B polymorphisms and cancer riskTo NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorIL-1 is required for tumor invasiveness and angiogenesisKey roles of necroptotic factors in promoting tumor growthIFN-gamma impairs release of IL-8 by IL-1beta-stimulated A549 lung carcinoma cells.Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.The role of chemoattractant receptors in shaping the tumor microenvironment.Immune cells in primary and metastatic gastrointestinal stromal tumors (GIST).Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes.Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young womenInterleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatmentStructure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme.Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesisMicroglia function in brain tumors.IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesisNox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice.Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation.The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.Cancer cell signaling pathways targeted by spice-derived nutraceuticals.Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy.NLRC4 suppresses melanoma tumor progression independently of inflammasome activation.Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.Prostate angiogenesis in development and inflammationThe role IL-1 in tumor-mediated angiogenesis.IL-1 drives breast cancer growth and bone metastasis in vivo.The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.
P2860
Q24564308-5AE02464-0A2F-4D58-9864-039DE90408B8Q24800666-0C4A6130-C20A-438C-8862-2EAEECCB0418Q26798034-E3166162-1A45-48A2-A881-2B973A497700Q27003989-C0712B7A-77F7-4402-9E69-78868AADB336Q27332126-C3DB3458-3AE9-4747-A05C-894E299EA9CDQ28069621-E87E4F3C-C82F-40B4-A83C-BFC4607E8F6BQ28076327-3004FD22-C800-4023-AE90-DBD7BEBB74CBQ28200420-04AC910B-0311-4BBC-8EEB-C049AF983A86Q28383264-BB0A31D1-B4A6-44E2-8AFB-E2ED20AC1C25Q28386593-070FE8CA-A755-4C96-8B99-6143F4F204D8Q28594748-BCAFE4E7-A5FF-41D2-B78E-1CE34154AA7DQ28828140-6BC681AF-6504-40F9-8E3D-D5AFE6E9AA7AQ33370417-CBD9AD3E-4389-4343-9C63-3F7C42D82817Q33954537-214FBCF6-F73D-4DC2-9CFE-D1D76979C013Q33993124-F6FCBFEC-4164-4CE6-9B03-4B24622ADD70Q34028872-08696DEB-1196-447D-8D3A-EE3CBA7655F7Q34190300-E5B8D0A1-4C4C-45AC-A052-BDE8A13B0DE7Q34473935-79D06BF1-5CAA-4AC3-85DD-6288E38D9A37Q34540533-2F563966-0CE2-468E-8D88-7389A0B69271Q34737360-CF1AD3F6-1B5A-4612-8896-7F464376C995Q35165663-BA560038-EA8E-4FFD-86B7-2C53896D0501Q35936086-86B96B61-8F81-41DF-8F82-1D947EF0828BQ35963152-FC332D2A-D5E6-42D6-B5D5-3CAE385BD3D2Q36108579-C640B946-C870-4AE8-92F2-2A616325135FQ36164949-A6EC08E6-3D7D-4846-AB54-0B1080DD57C5Q36193541-F9FB8BF1-EBCF-45CE-918B-1FBEDDF31963Q36202911-26E68041-95E2-426B-ABF3-2CA4BDA96C9FQ36572247-3223601B-9A8A-461C-AEBA-386DE063DE9BQ36573214-CF057BE7-FCA1-4D77-A212-6EC1176856D1Q36624543-02DE9475-3246-4E9A-A4B1-C1681566ACD3Q36819371-4FEE6C17-CF4E-4E1A-9076-4F68000A90BBQ37118170-609AD85E-60D3-4687-9AF8-B0504A87DF49Q37255282-45124F2D-D7EA-4B1F-8BD8-10223CA37C11Q37395723-C5EBB90E-084B-42D7-B796-D099270A0F6BQ37400654-8A30EB1A-FCAD-4082-ACC4-CB1E834758C0Q37484367-F65EED06-449B-4DA4-B2FC-A2418B777D39Q37513161-F22ADC56-2281-4668-B3E0-C0D80ECAA875Q37683553-4BF0624C-41B0-4340-BC09-37CEF2B2F42BQ37688987-8EB8DEF2-B526-4ABE-BB3F-36443923FA06Q37901519-298340FA-E6C8-4E61-B76B-F877A3EF1775
P2860
Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Proinflammatory cytokine IL-1 ...... of tumor-stromal interaction.
@en
Proinflammatory cytokine IL-1 ...... of tumor-stromal interaction.
@nl
type
label
Proinflammatory cytokine IL-1 ...... of tumor-stromal interaction.
@en
Proinflammatory cytokine IL-1 ...... of tumor-stromal interaction.
@nl
prefLabel
Proinflammatory cytokine IL-1 ...... of tumor-stromal interaction.
@en
Proinflammatory cytokine IL-1 ...... of tumor-stromal interaction.
@nl
P2093
P1476
Proinflammatory cytokine IL-1 ...... of tumor-stromal interaction.
@en
P2093
Kazuhiro Usui
Kouji Matsushima
Makoto Maemondo
Makoto Miki
Masashi Tanaka
Ryushi Tazawa
Takuji Suzuki
Toshiaki Kikuchi
Toshihiro Nukiwa
P304
P356
10.4049/JIMMUNOL.169.1.469
P407
P577
2002-07-01T00:00:00Z